The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study.
Insulin normally regulates appetite and metabolism through brain signaling, but resistance in this pathway can disrupt these processes, potentially contributing to obesity and related diseases.